Table 1 The number of mutated and non-mutated tumour areas in cases with the T1796A BRAF mutation
From: The T1799A point mutation is present in posterior uveal melanoma
| Â | Number of tumour areas dissected | Â | |
|---|---|---|---|
Mutation-positive cases | With the BRAF mutation | Without the BRAF mutation | Percentage of areas with mutation (%) |
A | 1 | 5 | 16.67 |
B | 1 | 4 | 20.0 |
C | 2 | 4 | 33.33 |
D | 1 | 4 | 20.0 |
E | 1 | 2 | 33.3 |
F | 2 | 2 | 50.0 |
Total | 8 | 21 | 38.10 |
